[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-001", "question": "A 14-year-old boy with juvenile idiopathic arthritis presents with acute onset of fever, rash, and joint swelling after starting etanercept therapy. Laboratory findings include elevated ferritin, pancytopenia, and hypertriglyceridemia. What is the most appropriate next step in management?", "options": ["Discontinue etanercept and initiate high-dose corticosteroids", "Administer intravenous immunoglobulin", "Start rituximab infusion", "Perform bone marrow biopsy immediately", "Initiate broad-spectrum antibiotics"], "answer": "A", "answer_index": 0, "explanation": "This presentation is consistent with macrophage activation syndrome (MAS), a life-threatening complication in rheumatic diseases like juvenile idiopathic arthritis, often triggered by biologic agents such as etanercept. Discontinuing the offending agent and starting high-dose corticosteroids is the initial management to control the cytokine storm. Bone marrow biopsy may confirm hemophagocytosis but is not the immediate next step, and antibiotics are inappropriate without evidence of infection.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 14-year-old with juvenile idiopathic arthritis on etanercept presents with acute fever, rash, joint swelling, marked hyperferritinemia, pancytopenia, and hypertriglyceridemia—diagnostic of macrophage activation syndrome (MAS), a life-threatening cytokine storm syndrome. The question asks the most appropriate next step. Option A (discontinue etanercept and initiate high-dose corticosteroids) correctly captures the emergent management: immediate removal of the triggering biologic and initiation of high-dose steroids (typically IV methylprednisolone pulses) per HLH-2004 and pediatric rheumatology guidelines. Alternatives are clearly inferior: IVIG (B) is not first-line; rituximab (C) is reserved for refractory disease; bone marrow biopsy (D) is confirmatory but should not delay therapy; broad-spectrum antibiotics (E) are inappropriate without clear infection. No internal contradictions; options permit clear discrimination. Medical accuracy is gold-standard: fully aligned with current consensus and board-relevant. Minimal fix: none required; item is board-ready.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: 14-year-old with juvenile idiopathic arthritis on etanercept presents with acute fever, rash, joint swelling, marked hyperferritinemia, pancytopenia, and hypertriglyceridemia—diagnostic of macrophage activation syndrome (MAS), a life-threatening cytokine storm syndrome. The question asks the most appropriate next step. Option A (discontinue etanercept and initiate high-dose corticosteroids) correctly captures the emergent management: immediate removal of the triggering biologic and initiation of high-dose steroids (typically IV methylprednisolone pulses) per HLH-2004 and pediatric rheumatology guidelines. Alternatives are clearly inferior: IVIG (B) is not first-line; rituximab (C) is reserved for refractory disease; bone marrow biopsy (D) is confirmatory but should not delay therapy; broad-spectrum antibiotics (E) are inappropriate without clear infection. No internal contradictions; options permit clear discrimination. Medical accuracy is gold-standard: fully aligned with current consensus and board-relevant. Minimal fix: none required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-002", "question": "A 65-year-old man with hypertrophic cardiomyopathy develops sudden syncope during exercise. Echocardiography shows left ventricular outflow tract obstruction with a gradient of 80 mmHg. Despite beta-blocker therapy, symptoms persist. What is the most definitive management option?", "options": ["Surgical septal myectomy", "Alcohol septal ablation", "Implantable cardioverter-defibrillator placement", "Dual-chamber pacing", "Verapamil initiation"], "answer": "A", "answer_index": 0, "explanation": "Surgical septal myectomy is the gold standard for symptomatic hypertrophic cardiomyopathy with severe outflow tract obstruction refractory to medical therapy, offering superior long-term outcomes in experienced centers. Alcohol septal ablation is an alternative but carries risks like heart block and is less effective in younger patients. ICD placement addresses arrhythmic risk but not the obstruction itself.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem presents a 65-year-old man with hypertrophic cardiomyopathy, severe LVOT obstruction (80 mmHg), exercise-induced syncope, and symptoms refractory to beta-blockade. These clues point to a patient needing definitive relief of mechanical obstruction. Surgical septal myectomy is the gold-standard, most definitive procedure for refractory symptomatic HCM with severe obstruction, offering immediate and complete gradient reduction. The phrasing 'most definitive' appropriately discriminates it from alcohol septal ablation (option B), which is less invasive but also less immediately definitive and carries higher heart block risk. ICD placement (C) addresses arrhythmic risk, not obstruction. Pacing (D) provides modest, variable gradient reduction. Verapamil (E) is inappropriate for severe obstruction refractory to beta-blockade. No internal contradictions exist; options are distinct and permit clear discrimination. Medical accuracy is sound: surgical myectomy remains guideline-endorsed first-line definitive therapy for suitable candidates. Minor nuance: the item omits surgical risk assessment, which in a 65-year-old could favor alcohol ablation, but 'most definitive' justifies the key. Minimal fix: add 'who is an acceptable surgical candidate' to the stem.\",\"medical_accuracy_score\":   \"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem presents a 65-year-old man with hypertrophic cardiomyopathy, severe LVOT obstruction (80 mmHg), exercise-induced syncope, and symptoms refractory to beta-blockade. These clues point to a patient needing definitive relief of mechanical obstruction. Surgical septal myectomy is the gold-standard, most definitive procedure for refractory symptomatic HCM with severe obstruction, offering immediate and complete gradient reduction. The phrasing 'most definitive' appropriately discriminates it from alcohol septal ablation (option B), which is less invasive but also less immediately definitive and carries higher heart block risk. ICD placement (C) addresses arrhythmic risk, not obstruction. Pacing (D) provides modest, variable gradient reduction. Verapamil (E) is inappropriate for severe obstruction refractory to beta-blockade. No internal contradictions exist; options are distinct and permit clear discrimination. Medical accuracy is sound: surgical myectomy remains guideline-endorsed first-line definitive therapy for suitable candidates. Minor nuance: the item omits surgical risk assessment, which in a 65-year-old could favor alcohol ablation, but 'most definitive' justifies the key. Minimal fix: add 'who is an acceptable surgical candidate' to the stem.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-003", "question": "A term neonate develops respiratory distress and hypotension shortly after birth. Physical exam reveals hepatomegaly and poor perfusion. Echocardiogram shows dilated cardiomyopathy. Maternal history includes untreated systemic lupus erythematosus. What is the underlying mechanism?", "options": ["Transplacental passage of anti-Ro/SSA antibodies causing atrioventricular block", "Congenital viral infection leading to myocarditis", "Inborn error of metabolism affecting cardiac function", "Asphyxia-induced hypoxic cardiomyopathy", "Genetic mutation in sarcomeric proteins"], "answer": "A", "answer_index": 0, "explanation": "Neonatal lupus from maternal anti-Ro/SSA antibodies can cause complete heart block and cardiomyopathy, leading to heart failure in the newborn. This is distinct from viral myocarditis, which typically presents later and lacks the maternal autoimmune history. Metabolic or genetic causes are less likely without additional syndromic features.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: The keyed answer A is the correct best answer. Key stem clues: term neonate with early-onset heart failure (respiratory distress, hypotension, hepatomegaly, poor perfusion) and dilated cardiomyopathy in the setting of maternal systemic lupus erythematosus. These findings strongly point to neonatal lupus mediated by transplacental anti‑Ro/SSA antibodies. The answer correctly identifies antibody passage as the mechanism. Alternative choices are less plausible: viral myocarditis lacks maternal autoimmune history; metabolic disease and genetic sarcomeric mutations would present without SLE; asphyxia‑related cardiomyopathy would have perinatal hypoxia details. Main logical issue: None; the stem provides a unique discriminating clue (maternal SLE) that makes A the only defensible mechanism. Minor medical accuracy issue: The answer mentions atrioventricular block, which is not described in the vignette; however, anti‑Ro/SSA can also cause myocardial injury leading to dilated cardiomyopathy, and the explanation clarifies this. Minimal fix: Rephrase option A to ‘Transplacental passage of anti‑Ro/SSA antibodies causing myocardial injury and dilated cardiomyopathy’ to align precisely with the stem.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: The keyed answer A is the correct best answer. Key stem clues: term neonate with early-onset heart failure (respiratory distress, hypotension, hepatomegaly, poor perfusion) and dilated cardiomyopathy in the setting of maternal systemic lupus erythematosus. These findings strongly point to neonatal lupus mediated by transplacental anti‑Ro/SSA antibodies. The answer correctly identifies antibody passage as the mechanism. Alternative choices are less plausible: viral myocarditis lacks maternal autoimmune history; metabolic disease and genetic sarcomeric mutations would present without SLE; asphyxia‑related cardiomyopathy would have perinatal hypoxia details. Main logical issue: None; the stem provides a unique discriminating clue (maternal SLE) that makes A the only defensible mechanism. Minor medical accuracy issue: The answer mentions atrioventricular block, which is not described in the vignette; however, anti‑Ro/SSA can also cause myocardial injury leading to dilated cardiomyopathy, and the explanation clarifies this. Minimal fix: Rephrase option A to ‘Transplacental passage of anti‑Ro/SSA antibodies causing myocardial injury and dilated cardiomyopathy’ to align precisely with the stem.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-004", "question": "A 28-year-old woman at 32 weeks gestation presents with severe preeclampsia and acute dyspnea. Echocardiography reveals peripartum cardiomyopathy with ejection fraction of 30%. What is the most critical intervention to improve maternal outcomes?", "options": ["Immediate delivery via cesarean section", "Initiate bromocriptine to suppress prolactin", "Administer intravenous furosemide and vasodilators", "Start anticoagulation with low-molecular-weight heparin", "Perform urgent cardiac transplantation evaluation"], "answer": "B", "answer_index": 1, "explanation": "Bromocriptine inhibits prolactin, which is implicated in the pathogenesis of peripartum cardiomyopathy, and has shown benefit in improving left ventricular function when added to standard heart failure therapy. Immediate delivery may be necessary for preeclampsia but does not directly address cardiomyopathy. Diuretics and vasodilators manage symptoms but are not disease-modifying in this context.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (Multiple answers defensible); secondary U (Underspecified). Verdict: Keyed answer not uniquely best. Key clues: 32-week severe preeclampsia mandates delivery; acute dyspnea with PPCM (EF 30%) requires urgent heart failure therapy. The term 'most critical intervention' is ambiguous—delivery (Option A) definitively treats preeclampsia and unloads the heart, while IV furosemide/vasodilators (Option C) address life-threatening pulmonary edema. Both are guideline-supported and arguably 'most critical' depending on maternal stability. Bromocriptine (Option B) is not standard-of-care; while some trials suggest prolactin inhibition may aid LV recovery, major guidelines do not recommend it as first-line or 'critical' therapy, and it does not address acute decompensation or preeclampsia. Medical accuracy is compromised by presenting an investigational agent as superior to established, life-saving measures. Minimal fix: Rephrase stem to specify 'in addition to standard heart failure therapy and delivery planning, which intervention has shown disease-modifying benefit in PPCM?' and revise key to reflect evidence-based adjunctive role of bromocriptine, or change key to C emphasizing acute stabilization.\",\"medical_accuracy_score\":   \"2\",\"logical_validity\": false,\"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (Multiple answers defensible); secondary U (Underspecified). Verdict: Keyed answer not uniquely best. Key clues: 32-week severe preeclampsia mandates delivery; acute dyspnea with PPCM (EF 30%) requires urgent heart failure therapy. The term 'most critical intervention' is ambiguous—delivery (Option A) definitively treats preeclampsia and unloads the heart, while IV furosemide/vasodilators (Option C) address life-threatening pulmonary edema. Both are guideline-supported and arguably 'most critical' depending on maternal stability. Bromocriptine (Option B) is not standard-of-care; while some trials suggest prolactin inhibition may aid LV recovery, major guidelines do not recommend it as first-line or 'critical' therapy, and it does not address acute decompensation or preeclampsia. Medical accuracy is compromised by presenting an investigational agent as superior to established, life-saving measures. Minimal fix: Rephrase stem to specify 'in addition to standard heart failure therapy and delivery planning, which intervention has shown disease-modifying benefit in PPCM?' and revise key to reflect evidence-based adjunctive role of bromocriptine, or change key to C emphasizing acute stabilization.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-005", "question": "In the ICU, a 55-year-old patient with septic shock on vasopressors develops acute kidney injury and metabolic acidosis. Despite fluid resuscitation, oliguria persists. Continuous renal replacement therapy is initiated. What is the most appropriate modality to optimize hemodynamic stability?", "options": ["Continuous venovenous hemodiafiltration with citrate anticoagulation", "Intermittent hemodialysis with bicarbonate buffer", "Sustained low-efficiency dialysis", "Peritoneal dialysis", "Continuous venovenous hemofiltration alone"], "answer": "A", "answer_index": 0, "explanation": "Continuous venovenous hemodiafiltration (CVVHDF) provides both convective and diffusive clearance, making it ideal for septic shock with acidosis, and citrate anticoagulation minimizes clotting while providing regional effects. Intermittent hemodialysis can cause hemodynamic instability in critically ill patients. Peritoneal dialysis is less efficient for rapid toxin removal in this setting.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem's critical features—septic shock requiring vasopressors, persistent oliguria, and metabolic acidosis—demand a continuous renal replacement modality that maximizes hemodynamic stability while correcting acid-base derangements. Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation (Option A) is uniquely suited: it combines convective and diffusive clearance for efficient acidosis correction, operates continuously to avoid fluid shifts, and uses regional citrate anticoagulation that prevents circuit clotting without systemic effects. Option E (CVVH alone) lacks diffusive clearance, making it less optimal for metabolic acidosis. Intermittent hemodialysis (B) risks hypotension from rapid solute/fluid removal; sustained low-efficiency dialysis (C) is less continuous; peritoneal dialysis (D) is inefficient and contraindicated with shock. The keyed answer reflects current critical care consensus. While anticoagulation is technically a separate prescription element, its inclusion in A represents standard-of-care bundling rather than a flaw. No medical inaccuracies or logical contradictions are present. Minimal fix: None required.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem's critical features—septic shock requiring vasopressors, persistent oliguria, and metabolic acidosis—demand a continuous renal replacement modality that maximizes hemodynamic stability while correcting acid-base derangements. Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation (Option A) is uniquely suited: it combines convective and diffusive clearance for efficient acidosis correction, operates continuously to avoid fluid shifts, and uses regional citrate anticoagulation that prevents circuit clotting without systemic effects. Option E (CVVH alone) lacks diffusive clearance, making it less optimal for metabolic acidosis. Intermittent hemodialysis (B) risks hypotension from rapid solute/fluid removal; sustained low-efficiency dialysis (C) is less continuous; peritoneal dialysis (D) is inefficient and contraindicated with shock. The keyed answer reflects current critical care consensus. While anticoagulation is technically a separate prescription element, its inclusion in A represents standard-of-care bundling rather than a flaw. No medical inaccuracies or logical contradictions are present. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-006", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops progressive dyspnea and dry cough. High-resolution CT shows subpleural reticular opacities and traction bronchiectasis. Pulmonary function tests reveal restrictive pattern. What is the most likely diagnosis?", "options": ["Methotrexate-induced interstitial lung disease", "Rheumatoid arthritis-associated usual interstitial pneumonia", "Hypersensitivity pneumonitis from environmental exposure", "Non-specific interstitial pneumonia", "Cryptogenic organizing pneumonia"], "answer": "B", "answer_index": 1, "explanation": "Rheumatoid arthritis can cause interstitial lung disease with a usual interstitial pneumonia pattern, which is more common than methotrexate toxicity in long-term users. Methotrexate-induced ILD typically presents acutely and improves upon discontinuation, unlike this progressive course. Hypersensitivity pneumonitis would show upper lobe predominance and different triggers.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues: RA (autoimmune risk), methotrexate use, progressive dyspnea/dry cough, subpleural reticular opacities with traction bronchiectasis on HRCT, restrictive PFTs. This radiologic pattern is pathognomonic for usual interstitial pneumonia (UIP). While methotrexate-induced ILD (A) is a consideration, it typically presents acutely/subacutely with diffuse ground-glass opacities and improves after drug discontinuation, unlike this progressive course. Hypersensitivity pneumonitis (C) would demonstrate upper lobe predominance and mosaic attenuation, requiring environmental exposure history. NSIP (D) shows predominant ground-glass opacities with less reticulation. COP (E) manifests as patchy consolidations, not subpleural reticulation. Thus, RA-associated UIP (B) is uniquely defensible as the most likely diagnosis. The item is logically valid with a single best answer. Medical accuracy is excellent: RA-ILD most commonly presents as UIP pattern, and distinguishing drug toxicity from disease-related ILD is a critical board concept. No contradictions. Fix: None required; item is board-ready.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: RA (autoimmune risk), methotrexate use, progressive dyspnea/dry cough, subpleural reticular opacities with traction bronchiectasis on HRCT, restrictive PFTs. This radiologic pattern is pathognomonic for usual interstitial pneumonia (UIP). While methotrexate-induced ILD (A) is a consideration, it typically presents acutely/subacutely with diffuse ground-glass opacities and improves after drug discontinuation, unlike this progressive course. Hypersensitivity pneumonitis (C) would demonstrate upper lobe predominance and mosaic attenuation, requiring environmental exposure history. NSIP (D) shows predominant ground-glass opacities with less reticulation. COP (E) manifests as patchy consolidations, not subpleural reticulation. Thus, RA-associated UIP (B) is uniquely defensible as the most likely diagnosis. The item is logically valid with a single best answer. Medical accuracy is excellent: RA-ILD most commonly presents as UIP pattern, and distinguishing drug toxicity from disease-related ILD is a critical board concept. No contradictions. Fix: None required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-007", "question": "A 2-year-old child with hypoplastic left heart syndrome post-Norwood procedure presents with cyanosis and metabolic acidosis. Echocardiography shows right ventricular dysfunction and tricuspid regurgitation. What is the most appropriate pharmacologic intervention?", "options": ["Milrinone infusion for inotropic support", "Prostaglandin E1 to maintain ductal patency", "Sildenafil for pulmonary hypertension", "Digoxin for rate control", "Epinephrine bolus for hypotension"], "answer": "A", "answer_index": 0, "explanation": "Milrinone provides inotropic support and pulmonary vasodilation, crucial for right ventricular failure in single-ventricle physiology after Norwood. Prostaglandin E1 is used preoperatively but not post-Norwood. Sildenafil targets pulmonary hypertension but lacks the inotropic effect needed here.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues of HLHS post-Norwood, cyanosis, metabolic acidosis, and echo showing RV dysfunction with tricuspid regurgitation collectively indicate acute systemic RV failure—the dominant pathology requiring inotropic support with pulmonary vasodilation. Milrinone (A) is the gold-standard phosphodiesterase-3 inhibitor providing both lusitropic/inotropic effects and pulmonary vasodilation without significantly increasing myocardial oxygen demand, making it ideal for single-ventricle RV failure. Alternatives are clearly inferior: PGE1 (B) is contraindicated post-Norwood (ductus ligated/Sano conduit); sildenafil (C) lacks inotropic support; digoxin (D) is insufficient for acute decompensation; epinephrine bolus (E) increases arrhythmia risk and myocardial demand. No internal contradictions exist; options permit clear discrimination. Medical accuracy is high and guideline-concordant. Minor issue: a 2-year-old is typically post-Glenn, but this does not invalidate the core pathophysiologic principle being tested. Minimal fix: specify acute postoperative timing (e.g., 'POD 2 after Norwood') to contextualize the RV failure presentation.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues of HLHS post-Norwood, cyanosis, metabolic acidosis, and echo showing RV dysfunction with tricuspid regurgitation collectively indicate acute systemic RV failure—the dominant pathology requiring inotropic support with pulmonary vasodilation. Milrinone (A) is the gold-standard phosphodiesterase-3 inhibitor providing both lusitropic/inotropic effects and pulmonary vasodilation without significantly increasing myocardial oxygen demand, making it ideal for single-ventricle RV failure. Alternatives are clearly inferior: PGE1 (B) is contraindicated post-Norwood (ductus ligated/Sano conduit); sildenafil (C) lacks inotropic support; digoxin (D) is insufficient for acute decompensation; epinephrine bolus (E) increases arrhythmia risk and myocardial demand. No internal contradictions exist; options permit clear discrimination. Medical accuracy is high and guideline-concordant. Minor issue: a 2-year-old is typically post-Glenn, but this does not invalidate the core pathophysiologic principle being tested. Minimal fix: specify acute postoperative timing (e.g., 'POD 2 after Norwood') to contextualize the RV failure presentation.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-008", "question": "A 70-year-old man with atrial fibrillation on anticoagulation develops acute chest pain and hypotension. Coronary angiography shows no obstructive disease, but left ventriculography reveals apical ballooning. What is the underlying pathophysiology?", "options": ["Catecholamine surge leading to transient myocardial stunning", "Spontaneous coronary artery dissection", "Myocarditis from viral infection", "Embolic occlusion of distal coronaries", "Vasospasm induced by ergonovine"], "answer": "A", "answer_index": 0, "explanation": "Takotsubo cardiomyopathy involves catecholamine-mediated myocardial stunning, mimicking acute coronary syndrome without angiographic abnormalities. Dissection would show vessel irregularities on angiography. Myocarditis typically presents with inflammatory markers and different ventricular patterns.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes Takotsubo cardiomyopathy with its triad of acute chest pain/hypotension, normal coronary angiography, and characteristic apical ballooning on ventriculography. The key discriminating clue is the apical ballooning pattern in the setting of unobstructed coronaries, which is pathognomonic for stress-induced cardiomyopathy. Option A correctly captures the established catecholamine-mediated pathophysiology. Each distractor is appropriately excluded based on explicit stem findings: spontaneous coronary dissection (B) would demonstrate vessel irregularities on angiography; viral myocarditis (C) typically shows inflammatory markers and lacks the classic ballooning morphology; distal embolic occlusion (D) is inconsistent with normal angiography and less likely on anticoagulation; ergonovine-induced vasospasm (E) is unsupported by the clinical scenario. No critical details are missing, and no unstated assumptions are required to select a unique best answer. The item is internally consistent, permits clear discrimination between options, and the keyed answer aligns perfectly with current medical consensus. Medical accuracy is gold-standard, reflecting contemporary understanding of Takotsubo pathophysiology per AHA/ESC statements. No revisions necessary.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes Takotsubo cardiomyopathy with its triad of acute chest pain/hypotension, normal coronary angiography, and characteristic apical ballooning on ventriculography. The key discriminating clue is the apical ballooning pattern in the setting of unobstructed coronaries, which is pathognomonic for stress-induced cardiomyopathy. Option A correctly captures the established catecholamine-mediated pathophysiology. Each distractor is appropriately excluded based on explicit stem findings: spontaneous coronary dissection (B) would demonstrate vessel irregularities on angiography; viral myocarditis (C) typically shows inflammatory markers and lacks the classic ballooning morphology; distal embolic occlusion (D) is inconsistent with normal angiography and less likely on anticoagulation; ergonovine-induced vasospasm (E) is unsupported by the clinical scenario. No critical details are missing, and no unstated assumptions are required to select a unique best answer. The item is internally consistent, permits clear discrimination between options, and the keyed answer aligns perfectly with current medical consensus. Medical accuracy is gold-standard, reflecting contemporary understanding of Takotsubo pathophysiology per AHA/ESC statements. No revisions necessary.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-009", "question": "A 35-year-old pregnant woman at 28 weeks with antiphospholipid syndrome develops thrombocytopenia and elevated liver enzymes. Fetal monitoring shows growth restriction. What is the most appropriate management strategy?", "options": ["Low-dose aspirin and low-molecular-weight heparin continuation with close monitoring", "Immediate delivery to prevent maternal deterioration", "Plasmapheresis for antibody removal", "Intravenous immunoglobulin infusion", "Switch to unfractionated heparin"], "answer": "A", "answer_index": 0, "explanation": "In antiphospholipid syndrome during pregnancy, continuing low-dose aspirin and LMWH is standard to manage thrombotic risks and prevent complications like HELLP-like syndrome, with vigilant monitoring. Immediate delivery is premature at 28 weeks without severe features. IVIG is not first-line and reserved for refractory cases.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (Underspecified). Verdict: Not uniquely determinable. Key stem clues: 28-week pregnancy, APS, thrombocytopenia, elevated liver enzymes, fetal growth restriction. These findings raise concern for APS-related complications versus HELLP/preeclampsia, but critical severity parameters are absent: platelet count, degree of enzyme elevation, blood pressure, maternal symptoms, and hemolysis status. Without these, the decision between continuing LDA+LMWH (A) and immediate delivery (B) hinges on unstated assumptions about disease severity, making multiple answers defensible (secondary M). Options C, D, and E are clearly inferior: plasmapheresis and IVIG are not first-line for APS in pregnancy, and UFH offers no advantage over LMWH. Main logical issue: Missing severity data prevents definitive selection of a single best answer. Main medical accuracy issue: The rationale overstates that LDA+LMWH 'prevents HELLP-like syndrome'—APS therapy prevents thrombosis, not HELLP pathogenesis; severe HELLP mandates delivery at any gestational age. Minimal fix: Add severity parameters (e.g., platelets 85,000/µL, AST 120 U/L, BP 110/70 mmHg, no hemolysis, asymptomatic) to clarify non-severe disease and justify continuation.\",\"medical_accuracy_score\":   \"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified). Verdict: Not uniquely determinable. Key stem clues: 28-week pregnancy, APS, thrombocytopenia, elevated liver enzymes, fetal growth restriction. These findings raise concern for APS-related complications versus HELLP/preeclampsia, but critical severity parameters are absent: platelet count, degree of enzyme elevation, blood pressure, maternal symptoms, and hemolysis status. Without these, the decision between continuing LDA+LMWH (A) and immediate delivery (B) hinges on unstated assumptions about disease severity, making multiple answers defensible (secondary M). Options C, D, and E are clearly inferior: plasmapheresis and IVIG are not first-line for APS in pregnancy, and UFH offers no advantage over LMWH. Main logical issue: Missing severity data prevents definitive selection of a single best answer. Main medical accuracy issue: The rationale overstates that LDA+LMWH 'prevents HELLP-like syndrome'—APS therapy prevents thrombosis, not HELLP pathogenesis; severe HELLP mandates delivery at any gestational age. Minimal fix: Add severity parameters (e.g., platelets 85,000/µL, AST 120 U/L, BP 110/70 mmHg, no hemolysis, asymptomatic) to clarify non-severe disease and justify continuation.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-010", "question": "In the critical care unit, a 60-year-old patient with acute respiratory distress syndrome on mechanical ventilation develops refractory hypoxemia despite prone positioning. Extracorporeal membrane oxygenation is considered. What is the primary indication for venovenous ECMO in this scenario?", "options": ["PaO2/FiO2 ratio less than 80 with FiO2 greater than 90%", "Hypercapnia unresponsive to increased minute ventilation", "Right ventricular failure on echocardiography", "Sepsis-induced myocardial depression", "Barotrauma from high plateau pressures"], "answer": "A", "answer_index": 0, "explanation": "Venovenous ECMO is indicated for severe ARDS when PaO2/FiO2 <80 on FiO2 >90%, despite optimal ventilatory support, to provide gas exchange. Hypercapnia alone may be managed with permissive strategies or ECCO2R. Right ventricular failure would prompt venoarterial ECMO consideration instead.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem presents severe ARDS with refractory hypoxemia despite prone positioning—the precise scenario where VV-ECMO is considered. Key discriminating clues: refractory hypoxemia (not hypercapnia or cardiac failure) and explicit request for VV-ECMO indication. Option A matches ELSO guidelines and major trials (EOLIA, CESAR) recommending VV-ECMO for PaO2/FiO2 <80 mmHg on FiO2 >90% after optimal ventilation. Alternatives are correctly excluded: B (hypercapnia) is managed via ECCO2R or permissive strategies; C (RV failure) and D (myocardial depression) require VA-ECMO for cardiac support; E (barotrauma) is a complication, not an indication. No contradictions exist, and options allow clear discrimination. Medical accuracy is excellent and board-relevant. A minimal enhancement would be specifying duration of refractory hypoxemia (e.g., >6 hours) for guideline precision, but this does not impair answer defensibility. The item is educationally sound and clinically accurate.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem presents severe ARDS with refractory hypoxemia despite prone positioning—the precise scenario where VV-ECMO is considered. Key discriminating clues: refractory hypoxemia (not hypercapnia or cardiac failure) and explicit request for VV-ECMO indication. Option A matches ELSO guidelines and major trials (EOLIA, CESAR) recommending VV-ECMO for PaO2/FiO2 <80 mmHg on FiO2 >90% after optimal ventilation. Alternatives are correctly excluded: B (hypercapnia) is managed via ECCO2R or permissive strategies; C (RV failure) and D (myocardial depression) require VA-ECMO for cardiac support; E (barotrauma) is a complication, not an indication. No contradictions exist, and options allow clear discrimination. Medical accuracy is excellent and board-relevant. A minimal enhancement would be specifying duration of refractory hypoxemia (e.g., >6 hours) for guideline precision, but this does not impair answer defensibility. The item is educationally sound and clinically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]